查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587364

綜合代謝面板測試市場：按疾病、測試類型、最終用戶分類 - 全球預測 2025-2030

Comprehensive Metabolic Panel Testing Market by Disease (Diabetes, Kidney Disease, Liver Disease), Test Type (Electrolytes, Glucose, Kidney Tests), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

綜合代謝面板測試市場2023年估值為92.8億美元，預計到2024年將達到102.6億美元，複合年成長率為10.65%，預計到2030年將達到188.6億美元。

綜合代謝組 (CMP) 測試市場包括各種診斷性血液測試，可測量血糖水平、電解質平衡、腎功能、肝臟狀態，並提供有關患者整體代謝健康狀況的重要資料。由於文明病和慢性病的增加，CMP檢測被廣泛應用於常規健康檢查和疾病進展監測。醫療保健提供者、實驗室和醫院是主要的最終用戶，而患者對預防性護理和就地檢驗解決方案的偏好的增加正在推動需求。市場洞察揭示了導致需求激增的關鍵成長要素，包括自動化測試技術的進步、向個人化醫療的轉變以及新興國家醫療保健基礎設施的擴張。潛在的機會存在於提高診斷準確性、整合人工智慧以更好地解釋資料以及開發家用可攜式測試設備。然而，監管障礙、與先進診斷工具相關的高成本以及某些地區缺乏意識等挑戰可能會阻礙市場成長。價格敏感度和報銷問題使市場動態更加複雜。隨著該行業尋求克服這些障礙，創新領域已經成熟，包括開發下一代生物標記物組、改進機器學習演算法以實現更好的診斷預測以及可訪問性和患者參與，其中包括遠端醫療平台和CMP 測試的整合以增加。隨著公私夥伴關係關係促進市場擴張，降低成本和提高意識的努力可以產生正面成果。 CMP 測試市場的基本性質很強大，但仍在不斷發展，主要是由技術整合以及對健康和福祉意識的重視所推動的。

主要市場統計
基準年[2023] 92.8億美元
預測年份 [2024] 102.6億美元
預測年份 [2030] 188.6億美元
複合年成長率（%） 10.65%

市場動態：快速發展的綜合代謝面板測試市場的關鍵市場洞察

供需的動態交互作用正在改變綜合代謝組測試市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病盛行率增加
    • 人群早期診斷和治療的潛在需求
    • 老年人口不斷增加，切片檢查過程不斷增加
  • 市場限制因素
    • 測試結果錯誤的可能性
  • 市場機會
    • 介紹旨在提高效率和減少錯誤的創新解決方案的興起
    • 實驗室自動化系統與生物資訊學和資料管理解決方案的持續整合
  • 市場挑戰
    • 由於監管體系的變化導致製造商之間的模糊性

波特的五力：駕馭綜合代謝面板測試市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更具彈性的市場地位。

PESTLE分析：了解綜合代謝面板測試市場的外部影響

外部宏觀環境因素在塑造綜合代謝組測試市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解綜合代謝組測試市場的競爭狀況

綜合代謝面板測試市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣綜合代謝組測試市場供應商績效評估

FPNV定位矩陣是評估綜合代謝組測試市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製綜合代謝面板測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對綜合代謝組測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病發生率增加
      • 人群早期診斷和治療的需要
      • 老年人口不斷增加，切片檢查數量不斷增加
    • 抑制因素
      • 測試給出錯誤結果的機率
    • 機會
      • 介紹可提高效率並減少錯誤的創新解決方案
      • 生物資訊學和資料管理解決方案與實驗室自動化系統的持續整合
    • 任務
      • 監管體系的變化在製造商之間造成了模糊性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章綜合代謝面板測試市場：依疾病分類

  • 糖尿病
  • 腎臟疾病
  • 肝臟疾病

第7章按測試類型分類的綜合代謝組測試市場

  • 電解質
  • 葡萄糖
  • 腎臟測試
  • 肝功能檢查
  • 蛋白質

第8章綜合代謝組測試市場：依最終用戶分類

  • 實驗室
  • 概念驗證

第9章北美和南美綜合代謝組測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區綜合代謝組測試市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲綜合代謝組檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abaxis by Zoetis Inc.
  • Abbott Laboratories
  • ARUP Laboratories
  • Baptist Health Medical Group
  • CENTOGENE NV
  • Cleveland HeartLab, Inc.
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories, Inc.
  • Private MD Labs
  • Quest Diagnostics Incorporated
  • Scion Lab Services, LLC
  • Siemens Healthcare GmbH
  • SYNLAB International GmbH
  • Testing.com by OneCare Media
  • Walk-In Lab, LLC
Product Code: MRR-ED54C46E80B0

The Comprehensive Metabolic Panel Testing Market was valued at USD 9.28 billion in 2023, expected to reach USD 10.26 billion in 2024, and is projected to grow at a CAGR of 10.65%, to USD 18.86 billion by 2030.

The Comprehensive Metabolic Panel (CMP) testing market encompasses a wide range of diagnostic blood tests that measure glucose levels, electrolyte balance, kidney function, and liver status to provide essential data on a patient's overall metabolic health. Necessitated by the growing incidence of lifestyle-related disorders and chronic diseases, CMP testing finds extensive application in both routine health examinations and the monitoring of disease progression. Healthcare providers, laboratories, and hospitals serve as primary end-users, while the increasing patient preference for preventive healthcare and point-of-care testing solutions drives demand. Market insights reveal key growth factors, such as advancements in automated testing technologies, the shift towards personalized medicine, and expanding healthcare infrastructure in emerging economies, which contribute significantly to the demand surge. Potential opportunities exist in enhancing diagnostic accuracy, integrating artificial intelligence for better data interpretation, and developing portable testing equipment for home use. However, challenges such as regulatory hurdles, high costs associated with advanced diagnostic tools, and a lack of awareness in certain regions could hinder market growth. Price sensitivity and reimbursement issues further complicate market dynamics. As the industry aims to cross these hurdles, areas ripe for innovation include the development of next-generation biomarker panels, improvement in machine learning algorithms for better diagnostic predictions, and the integration of telehealth platforms with CMP testing to enhance accessibility and patient engagement. Efforts towards reducing costs and promoting awareness could yield favorable outcomes, with partnerships between private and public sectors fostering market expansion. The underlying nature of the CMP testing market is robust yet evolving, primarily driven by technological integration and a strong emphasis on health and well-being awareness, presenting a compelling case for stakeholders to invest in future-forward diagnostics.

KEY MARKET STATISTICS
Base Year [2023] USD 9.28 billion
Estimated Year [2024] USD 10.26 billion
Forecast Year [2030] USD 18.86 billion
CAGR (%) 10.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Comprehensive Metabolic Panel Testing Market

The Comprehensive Metabolic Panel Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of chronic diseases
    • Potential need for early diagnosis and treatment among the population
    • Rising elderly population coupled with increase in biopsy processes
  • Market Restraints
    • Probability of false results on testing
  • Market Opportunities
    • Emerging introduction of innovative solutions to improve efficiency and reduce errors
    • Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
  • Market Challenges
    • Changing regulatory system creating ambiguity among manufacturers

Porter's Five Forces: A Strategic Tool for Navigating the Comprehensive Metabolic Panel Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Comprehensive Metabolic Panel Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Comprehensive Metabolic Panel Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Comprehensive Metabolic Panel Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Comprehensive Metabolic Panel Testing Market

A detailed market share analysis in the Comprehensive Metabolic Panel Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Comprehensive Metabolic Panel Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Comprehensive Metabolic Panel Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Comprehensive Metabolic Panel Testing Market

A strategic analysis of the Comprehensive Metabolic Panel Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Comprehensive Metabolic Panel Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis by Zoetis Inc., Abbott Laboratories, ARUP Laboratories, Baptist Health Medical Group, CENTOGENE N.V., Cleveland HeartLab, Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., Private MD Labs, Quest Diagnostics Incorporated, Scion Lab Services, LLC, Siemens Healthcare GmbH, SYNLAB International GmbH, Testing.com by OneCare Media, and Walk-In Lab, LLC.

Market Segmentation & Coverage

This research report categorizes the Comprehensive Metabolic Panel Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease, market is studied across Diabetes, Kidney Disease, and Liver Disease.
  • Based on Test Type, market is studied across Electrolytes, Glucose, Kidney Tests, Liver Functional Tests, and Proteins.
  • Based on End-User, market is studied across Laboratory and PoC.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic diseases
      • 5.1.1.2. Potential need for early diagnosis and treatment among the population
      • 5.1.1.3. Rising elderly population coupled with increase in biopsy processes
    • 5.1.2. Restraints
      • 5.1.2.1. Probability of false results on testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging introduction of innovative solutions to improve efficiency and reduce errors
      • 5.1.3.2. Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Changing regulatory system creating ambiguity among manufacturers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Comprehensive Metabolic Panel Testing Market, by Disease

  • 6.1. Introduction
  • 6.2. Diabetes
  • 6.3. Kidney Disease
  • 6.4. Liver Disease

7. Comprehensive Metabolic Panel Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Electrolytes
  • 7.3. Glucose
  • 7.4. Kidney Tests
  • 7.5. Liver Functional Tests
  • 7.6. Proteins

8. Comprehensive Metabolic Panel Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Laboratory
  • 8.3. PoC

9. Americas Comprehensive Metabolic Panel Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Comprehensive Metabolic Panel Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Comprehensive Metabolic Panel Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abaxis by Zoetis Inc.
  • 2. Abbott Laboratories
  • 3. ARUP Laboratories
  • 4. Baptist Health Medical Group
  • 5. CENTOGENE N.V.
  • 6. Cleveland HeartLab, Inc.
  • 7. Laboratory Corporation of America Holdings
  • 8. NeoGenomics Laboratories, Inc.
  • 9. Private MD Labs
  • 10. Quest Diagnostics Incorporated
  • 11. Scion Lab Services, LLC
  • 12. Siemens Healthcare GmbH
  • 13. SYNLAB International GmbH
  • 14. Testing.com by OneCare Media
  • 15. Walk-In Lab, LLC

LIST OF FIGURES

  • FIGURE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPREHENSIVE METABOLIC PANEL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER FUNCTIONAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY POC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2023